JP2024518413A - 修飾ヌクレアーゼ - Google Patents
修飾ヌクレアーゼ Download PDFInfo
- Publication number
- JP2024518413A JP2024518413A JP2023568340A JP2023568340A JP2024518413A JP 2024518413 A JP2024518413 A JP 2024518413A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2024518413 A JP2024518413 A JP 2024518413A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- sequence
- cell
- nls
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
- C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
- C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185315P | 2021-05-06 | 2021-05-06 | |
| US63/185,315 | 2021-05-06 | ||
| US202263315483P | 2022-03-01 | 2022-03-01 | |
| US63/315,483 | 2022-03-01 | ||
| PCT/US2022/028208 WO2022236147A1 (en) | 2021-05-06 | 2022-05-06 | Modified nucleases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024518413A true JP2024518413A (ja) | 2024-05-01 |
| JPWO2022236147A5 JPWO2022236147A5 (https=) | 2025-05-13 |
| JP2024518413A5 JP2024518413A5 (https=) | 2025-05-13 |
Family
ID=81975392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568340A Pending JP2024518413A (ja) | 2021-05-06 | 2022-05-06 | 修飾ヌクレアーゼ |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20260009009A1 (https=) |
| JP (1) | JP2024518413A (https=) |
| CA (1) | CA3218053A1 (https=) |
| WO (1) | WO2022236147A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024007790A (es) | 2021-12-22 | 2024-09-06 | Camp4 Therapeutics Corp | Modulación de la transcripción génica utilizando oligonucleótidos antisentido dirigidos a arn reguladores. |
| IL324634A (en) | 2023-05-15 | 2026-01-01 | Nchroma Bio Inc | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2026046724A1 (en) * | 2024-08-30 | 2026-03-05 | Cellectis Sa | Tale protein scaffolds involving fusions of monopartite and bipartite nls |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020109412A1 (en) * | 2018-11-28 | 2020-06-04 | Keygene N.V. | Targeted enrichment by endonuclease protection |
| JP2020530264A (ja) * | 2017-06-23 | 2020-10-22 | インスクリプタ, インコーポレイテッド | 核酸誘導型ヌクレアーゼ |
| US20200354703A1 (en) * | 2018-10-22 | 2020-11-12 | Inscripta, Inc. | Engineered enzymes |
| WO2021067788A1 (en) * | 2019-10-03 | 2021-04-08 | Artisan Development Labs, Inc. | Crispr systems with engineered dual guide nucleic acids |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| WO2017106569A1 (en) * | 2015-12-18 | 2017-06-22 | The Regents Of The University Of California | Modified site-directed modifying polypeptides and methods of use thereof |
| US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US10011849B1 (en) * | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US11649442B2 (en) * | 2017-09-08 | 2023-05-16 | The Regents Of The University Of California | RNA-guided endonuclease fusion polypeptides and methods of use thereof |
| WO2019118516A1 (en) * | 2017-12-11 | 2019-06-20 | Editas Medicine, Inc. | Cpf1-related methods and compositions for gene editing |
| EP3821008A1 (en) * | 2018-07-12 | 2021-05-19 | Keygene N.V. | Type v crispr/nuclease-system for genome editing in plant cells |
| WO2020092057A1 (en) * | 2018-10-30 | 2020-05-07 | Yale University | Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells |
| CN113039278A (zh) * | 2018-10-31 | 2021-06-25 | 诺维信公司 | 通过指导的内切核酸酶和单链寡核苷酸进行基因组编辑 |
| CA3153700A1 (en) * | 2019-09-09 | 2021-03-18 | Scribe Therapeutics Inc. | Compositions and methods for use in immunotherapy |
| US20230348869A1 (en) * | 2019-10-14 | 2023-11-02 | KWS SAAT SE & Co. KGaA | Mad7 nuclease in plants and expanding its pam recognition capability |
| CA3166430A1 (en) | 2020-02-05 | 2021-08-12 | Ryan T. Gill | Compositions and methods for targeting, editing or modifying human genes |
-
2022
- 2022-05-06 CA CA3218053A patent/CA3218053A1/en active Pending
- 2022-05-06 WO PCT/US2022/028208 patent/WO2022236147A1/en not_active Ceased
- 2022-05-06 US US18/289,723 patent/US20260009009A1/en active Pending
- 2022-05-06 JP JP2023568340A patent/JP2024518413A/ja active Pending
-
2023
- 2023-04-28 US US18/141,363 patent/US20230340437A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020530264A (ja) * | 2017-06-23 | 2020-10-22 | インスクリプタ, インコーポレイテッド | 核酸誘導型ヌクレアーゼ |
| US20200354703A1 (en) * | 2018-10-22 | 2020-11-12 | Inscripta, Inc. | Engineered enzymes |
| WO2020109412A1 (en) * | 2018-11-28 | 2020-06-04 | Keygene N.V. | Targeted enrichment by endonuclease protection |
| WO2021067788A1 (en) * | 2019-10-03 | 2021-04-08 | Artisan Development Labs, Inc. | Crispr systems with engineered dual guide nucleic acids |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230340437A1 (en) | 2023-10-26 |
| US20260009009A1 (en) | 2026-01-08 |
| CA3218053A1 (en) | 2022-11-10 |
| WO2022236147A1 (en) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115698278B (zh) | 包含Cas12i2变体多肽的组合物及其用途 | |
| KR102666695B1 (ko) | Rna를 편집하기 위한 방법 및 조성물 | |
| KR102851101B1 (ko) | Rna를 편집하기 위한 방법 및 조성물 | |
| US11667903B2 (en) | Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9 | |
| CA3036926C (en) | Modified stem cell memory t cells, methods of making and methods of using same | |
| US20230340437A1 (en) | Modified nucleases | |
| AU2020358863A1 (en) | CRISPR systems with engineered dual guide nucleic acids | |
| EP4388105A1 (en) | Persistent allogeneic modified immune cells and methods of use thereof | |
| US20250179481A1 (en) | Compositions and methods for targeting, editing, or modifying genes | |
| JP2024501892A (ja) | 新規の核酸誘導型ヌクレアーゼ | |
| US20250115903A1 (en) | Compositions and methods for editing genomes | |
| US20250388896A1 (en) | Composition and methods for transgene insertion | |
| HK40081918B (en) | Methods and compositions for editing rna | |
| WO2025259791A1 (en) | Compositions and methods for tnpb and ωrna mediated targeting | |
| WO2026083309A1 (en) | Use of inhibitors or modulators of artemis in gene editing | |
| HK40081918A (en) | Methods and compositions for editing rna | |
| KR20250021340A (ko) | 유전자 및 세포 치료를 위한 tale 염기 편집기 | |
| EP4601650A2 (en) | Compositions and methods for targeting, editing, or modifying genes | |
| CN117136233A (zh) | 包含变体Cas12i4多肽的组合物及其用途 | |
| HK40061041A (en) | Methods and compositions for editing rnas | |
| HK40056042A (en) | Methods and compositions for editing rnas | |
| HK40056042B (en) | Methods and compositions for editing rnas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250501 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250501 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260217 |